|
LIG3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.181200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.972300E-02 |
| Normal-vs-Stage2 |
8.780000E-01 |
| Normal-vs-Stage3 |
2.940600E-01 |
| Normal-vs-Stage4 |
4.292400E-01 |
| Stage1-vs-Stage2 |
4.090800E-01 |
| Stage1-vs-Stage3 |
8.992400E-02 |
| Stage1-vs-Stage4 |
8.107000E-01 |
| Stage2-vs-Stage3 |
3.303000E-01 |
| Stage2-vs-Stage4 |
7.566800E-01 |
| Stage3-vs-Stage4 |
1.960000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.221400E-01 |
| Normal-vs-AfricanAmerican |
4.132000E-02 |
| Normal-vs-Asian |
5.294200E-01 |
| Caucasian-vs-AfricanAmerican |
8.876200E-02 |
| Caucasian-vs-Asian |
4.867000E-01 |
| AfricanAmerican-vs-Asian |
3.554600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.408200E-02 |
| Normal-vs-Female |
3.571600E-02 |
| Male-vs-Female |
6.964800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.363800E-01 |
| Normal-vs-Extreme_Weight |
4.545800E-02 |
| Normal-vs-Obese |
8.059000E-01 |
| Normal-vs-Extreme_Obese |
2.769000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.639000E-01 |
| Normal_Weight-vs-Obese |
4.855600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.088800E-01 |
| Extreme_Weight-vs-Obese |
7.186100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.826800E-01 |
| Obese-vs-Extreme_Obese |
3.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.901600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.132600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.286200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.793600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.103760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060130E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.536860E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.075800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.408300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.010200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.317400E-01 |
| Normal-VS-Type2 PRCC |
7.862000E-01 |
| Normal-VS-KIRP CIMP |
2.861800E-01 |
| Normal-VS-Unclassified PRCC |
6.252200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.340000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.068100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.039400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.090600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.841600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.951800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.848600E-01 |
| Normal-vs-N1 |
2.351600E-01 |
| Normal-vs-N2 |
3.042000E-01 |
| N0-vs-N1 |
1.238830E-01 |
| N0-vs-N2 |
9.139900E-02 |
| N1-vs-N2 |
5.262000E-01 |
|
|
